CERENIS THERAPEUTICS |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-.--% | -.--% |
| 14/03 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
| 11/03 | Abionyx: reduced net loss in 2023 | CF |
Evolution of the average Target Price on Cerenis Therapeutics
Price target over the last 5 years
History of analyst recommendation changes
e6cd.w67YxGrndMNGjDpjwnVVMEtw1sIw8mJgyf_U3xmiFD4.p8adkQ23MpMX_F4TlhABBXkohK0HtjMikLiOrCzvV1qRzb2tPKojgnHgCg~5705ca1aa39b4301e65ff920eb77d8f9
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.09
EUR
Average target price
10.5
EUR
Spread / Average Target
+863.30%
High Price Target
10.5
EUR
Spread / Highest target
+863.30%
Low Price Target
10.5
EUR
Spread / Lowest Target
+863.30%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- ABNX Stock
- 0RAG Stock
- Consensus Cerenis Therapeutics
